Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Persistent Endometrial Carcinoma”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Early research (Phase 1)UnknownNCT01454479
What this trial is testing

A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma

Who this might be right for
Recurrent Endometrial Cancer
Hung-Hsueh Chou 24
Testing effectiveness (Phase 2)Study completedNCT00087100
What this trial is testing

Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03835819
What this trial is testing

Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

Who this might be right for
Endometrial Cancer
Dana-Farber Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00377520
What this trial is testing

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
NeoplasmsNeoplasms by SiteUrogenital Neoplasms+8 more
Eli Lilly and Company 27
Testing effectiveness (Phase 2)Ended earlyNCT03077698
What this trial is testing

An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Xenetic Biosciences, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00027690
What this trial is testing

Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus Carcinoma
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT02725268
What this trial is testing

Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Millennium Pharmaceuticals, Inc. 241
Testing effectiveness (Phase 2)Study completedNCT00096447
What this trial is testing

Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Recurrent Endometrial Carcinoma
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00023894
What this trial is testing

Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00462826
What this trial is testing

VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Recurrent Endometrial Carcinoma
National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Study completedNCT00122343
What this trial is testing

AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)

Who this might be right for
Endometrial Cancer
Merck Sharp & Dohme LLC 45
Not applicableStudy completedNCT02093546
What this trial is testing

Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290

Who this might be right for
Recurrent Endometrial Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02912572
What this trial is testing

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

Who this might be right for
Metastatic Endometrial Cancer
Dana-Farber Cancer Institute 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT03348631
What this trial is testing

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Malignant Uterine Corpus NeoplasmRecurrent Ovarian Carcinoma+2 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)UnknownNCT02064725
What this trial is testing

Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA

Who this might be right for
Recurrent or Persistent Endometrial Carcinoma
Kevelt AS 8
Testing effectiveness (Phase 2)Study completedNCT01132820
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Study completedNCT01455493
What this trial is testing

GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma

Who this might be right for
Endometrial Carcinoma
Genentech, Inc. 56
Testing effectiveness (Phase 2)WithdrawnNCT00003821
What this trial is testing

Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer

Who this might be right for
Endometrial Cancer
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07139977
What this trial is testing

Study of EV for Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
William Bradley 12
Load More Results